Decitabine-Vorinostat combination treatment in acute myeloid leukemia activates pathways with potential for novel triple therapy.

about

Anexelekto/MER tyrosine kinase inhibitor ONO-7475 arrests growth and kills FMS-like tyrosine kinase 3-internal tandem duplication mutant acute myeloid leukemia cells by diverse mechanisms.Megakaryocyte lineage development is controlled by modulation of protein acetylation.

P2860

Q47142820-73DA390B-500F-4D56-A1EA-106CBC781B1D Q52716487-DCC413CD-7166-434B-ACDB-C4363EA72288

P2860

Decitabine-Vorinostat combination treatment in acute myeloid leukemia activates pathways with potential for novel triple therapy.

Item

http://www.wikidata.org/entity/Q41612823

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Decitabine-Vorinostat combinat ...... tial for novel triple therapy.

@en

type

Item

label

Decitabine-Vorinostat combinat ...... tial for novel triple therapy.

@en

prefLabel

Decitabine-Vorinostat combinat ...... tial for novel triple therapy.

@en

P1476

Decitabine-Vorinostat combinat ...... tial for novel triple therapy.

@en

P2093

Christine S Young

http://www.w3.org/2001/XMLSchema#string

Ken I Mills

http://www.w3.org/2001/XMLSchema#string

Laura M Kettyle

http://www.w3.org/2001/XMLSchema#string

P2860

An integrated encyclopedia of DNA elements in the human genome

Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex

AXL kinase as a novel target for cancer therapy

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

Decitabine and vorinostat cooperate to sensitize colon carcinoma cells to Fas ligand-induced apoptosis in vitro and tumor suppression in vivo

Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration

A comparison of azacitidine and decitabine activities in acute myeloid leukemia cell lines

Twist mediates suppression of inflammation by type I IFNs and Axl

MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin

P304

51429-51446

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.18009

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alex Thompson

Kathryn M Clarke

P577

2017-05-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28881658

http://www.w3.org/2001/XMLSchema#string

P932

5584259

http://www.w3.org/2001/XMLSchema#string

Decitabine-Vorinostat combination treatment in acute myeloid leukemia activates pathways with potential for novel triple therapy.

about

P2860

P2860

Decitabine-Vorinostat combination treatment in acute myeloid leukemia activates pathways with potential for novel triple therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932